Home » Topics » Regulatory » Patents

Patents
RSS

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Bayer describes new ASA derivatives

Dec. 19, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Sandoz reports on tetraline derivatives for neurological disorders

Dec. 18, 1996

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Dec. 18, 1996

Antiangiogenic compounds described by Taiho

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.